Agenda

Mr. Lybrand is Executive Director, International Health Systems Policy with Amgen, and is based in Amgen’s European hub in Switzerland.  He is a highly experienced market access and health policy leader.  He has over 20 years’ experience in health, having started his research and health outcomes-focused career in academia in Australia, preparing evidence-based reviews for the Cochrane Collaboration and undertaking health outcomes research in rheumatology.  

He has worked across many different regions, therapeutic areas and health care contexts, and has established a range of important partnerships in health, including with academic centres, digital health agencies, and national governments. A key personal highlight of his partnership was the development and initiation of the first public-private partnership for HPV vaccination in the developing world – initiating a national HPV vaccination program in Bhutan which is ongoing and has recently passed its 12th anniversary. 

Mr. Lybrand was previously a Board member of the Australian Cervical Cancer Foundation.  Aside from his Amgen role, he has an appointment as Adjunct Fellow at the Centre for the Health Economy at Macquarie University in Sydney, Australia.

During his more than 20-years at Lilly, Rich has held several managerial and leadership roles, responsible for IT infrastructure, delivery and support functions. He began his career at Lilly in the U.K. and in 2013, moved to the U.S. to support various business units and functions. Rich was responsible for leading the development of the global customer support program strategy. Most recently, Rich served as Senior Director of Systems Delivery in Digital Health where he led the software development and delivery teams responsible for the development of software-as-a-medical-device products.

Dr. Yuka Sumi is acting head of the Ageing and Health Unit at WHO. She is responsible WHOs work on Integrated Care for Older People (ICOPE) approach. She was involved in the publication of ICOPE guidelines in 2017, and led the development of ICOPE package of tools such as ICOPE handbook and digital app: guidance for person-centred assessment and pathways in primary care in 2019. She acts as a secretariat for WHO's Clinical Consortium on Healthy ageing (CCHA) coordinating the ICOPE pilots and implementation and development of Intrinsic Capacity Assessment tool. Yuka holds an MD, PhD and MPH.  

Michael W. Hodin, Ph.D. is CEO of the Global Coalition on Aging, Managing Partner at High Lantern Group, and a Fellow at Oxford University’s Harris Manchester College. He has spoken internationally on the topic of aging, including at G20, APEC, Davos, and the World Knowledge Forum (WKF). He is also a blogger on Medium.

From 1976-80, Mike was Legislative Assistant to Senator Daniel Patrick Moynihan. During this period he was also a Visiting Scholar at Brookings Institution, on U.S. Foreign Economic Policy. He was a senior executive at Pfizer, Inc. for 30 years, where he created and then led its International Public Affairs and Public Policy operations and served on Management Boards for a number of its businesses.

Mike is a Member of the Council on Foreign Relations, and from 2010-2013, was Adjunct Senior Fellow with a focus on population aging. Mike was also the recipient of the 2012 Fred D. Thompson Award from the American Federation for Aging Research. He sits on the Boards of the Foreign Policy Association, Business Council for International Understanding, American Skin Association, American Federation for Aging Research and Emigrant Savings Bank. Mike was a member of the World Economic Forum’s Global Agenda Council on Ageing. And he sits on the Advisory Board for the Milken Institute Center for the Future of Aging.

Mike holds a BA, cum laude, Cornell University, M.Sc.in International Relations from The London School of Economics and Political Science, and M.Phil and Ph.D. in Political Science from Columbia University.

Irina Kalderon Libal’s career has spanned the European Commission, the UN OHCHR and UNESCO. Her professional areas of focus include active and healthy ageing, health innovation, digital health, and sustainability of health and care systems.

Hidenori Arai (MD., PhD) is the President of the National Center for Geriatrics and Gerontology (NCGG), Japan since 2019. He is also the President of the Japan Gerontological Society, the Vice President of the Japan Geriatrics Society, the President of the Japanese Association on Sarcopenia and Frailty and the Vice President of the Japan Atherosclerosis Society. Additionally, he is the President of Asian Academy of Medicine for Ageing, and the Vice President of Asian Association of Frailty and Sarcopenia. He is a member of the Science Council of Japan since Oct. 2020. After graduating from Kyoto University School of Medicine in 1984 and from Kyoto University Graduate School of Medicine in 1991, Dr. Arai spent most of his career in the Department of Geriatric Medicine, Kyoto University. Then he became Professor of the Department of Human Health Science, Kyoto University School of Medicine in 2009 and since then he has been working on frailty and sarcopenia. After the work in the Department of Human Health Science, Kyoto University School of Medicine, he moved to NCGG as the Deputy Director in 2015. He then became the Director of NCGG in 2018 and the President of NCGG in 2019. He is the co-chair of the Asian Working Group for Sarcopenia and his primary research focus is frailty and sarcopenia.

Professor Ian Philp is the founder of Age Care Technologies (ACT) www.agecaretechnologies.org. ACT is the winner of the 2021 United Nations WSIS prize for innovation in healthy ageing for our potential to add 100 million quality life years for older people and reduce global costs of long-term care by $45 trillion.
 
Professor Philp is an advisor to the World Health Organisation in person-centred care for older people. He holds a Doctorate in Medicine from the University of Edinburgh and was a practicing physician for 35 years in the UK National Health Service, spending eight years an Executive Medical Director.
 
As Professor of Health Care for Older People at the University of Sheffield, he led teams which won the UK hospital team of the year in the care of older people and the Queen’s Anniversary Prize for Higher Education for research into improving the quality of life of older people.
 
From 2000-8, he was the National Clinical Director for Older People in England, leading the development and implementation of the National Service Framework for Older People, campaigning to ensure respect for dignity in care and eliminate age discrimination, leading national strategies for intermediate care, stroke, dementia and the prevention of falls and fractures.
 
Professor Philp was awarded a CBE in the Queen’s birthday honours in 2009 in recognition of his work to improve the lives of older people.